Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Arruda

Showing results (141-150 of 185) with videos related to

Pageof 19
Sort By:
Thrombosis Research|September 7, 2018
Padua FIXa resistance to Protein S and a potential therapy for hyperactive FIXaWilliam E Plautz, Rima Chattopadhyay, Ester I Goldfeld, et al.
Human Heredity|November 1, 1994
Sickle cell disease in a Brazilian population from Sao Paulo: a study of the beta s haplotypesM S Goncalves, J F Nechtman, M S Figueiredo, et al.
Blood|October 30, 2008
Long-term correction of inhibitor-prone hemophilia B dogs treated with liver-directed AAV2-mediated factor IX gene therapyGlenn P Niemeyer, Roland W Herzog, Jane Mount, et al.
Journal of Thrombosis and Haemostasis : JTH|October 18, 2016
Novel factor VIII variants with a modified furin cleavage site improve the efficacy of gene therapy for hemophilia AG N Nguyen, L A George, J I Siner, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 30, 2017
A Novel Platform for Immune Tolerance Induction in Hemophilia A MiceSimone Merlin, Elvira Stefania Cannizzo, Ester Borroni, et al.
Thrombosis and Haemostasis|June 30, 2006
Early in vivo anticoagulation inhibits the angiogenic response following hindlimb ischemia in a rodent modelErich V De Paula, Mariane C F Nascimento, Celso D Ramos, et al.
Blood|May 16, 2014
Omental implantation of BOECs in hemophilia dogs results in circulating FVIII antigen and a complex immune responseMargareth C Ozelo, Barbara Vidal, Christine Brown, et al.
Human Gene Therapy|August 7, 2002
Influence of vector dose on factor IX-specific T and B cell responses in muscle-directed gene therapyRoland W Herzog, Paul A Fields, Valder R Arruda, et al.
American Journal of Hematology|January 1, 1994
Beta S-gene-cluster haplotypes in sickle cell anemia patients from two regions of BrazilF F Costa, V R Arruda, M G Gonçalves, et al.
Journal of Thrombosis and Haemostasis : JTH|February 26, 2021
Factor IX assay discrepancies in the setting of liver gene therapy using a hyperfunctional variant factor IX-PaduaMary M Robinson, Lindsey A George, Marcus E Carr, et al.
Pageof 19

Showing results (141-150 of 185) with videos related to

Sort By:
Pageof 19
Thrombosis Research|September 7, 2018
Padua FIXa resistance to Protein S and a potential therapy for hyperactive FIXaWilliam E Plautz, Rima Chattopadhyay, Ester I Goldfeld, et al.
Human Heredity|November 1, 1994
Sickle cell disease in a Brazilian population from Sao Paulo: a study of the beta s haplotypesM S Goncalves, J F Nechtman, M S Figueiredo, et al.
Blood|October 30, 2008
Long-term correction of inhibitor-prone hemophilia B dogs treated with liver-directed AAV2-mediated factor IX gene therapyGlenn P Niemeyer, Roland W Herzog, Jane Mount, et al.
Journal of Thrombosis and Haemostasis : JTH|October 18, 2016
Novel factor VIII variants with a modified furin cleavage site improve the efficacy of gene therapy for hemophilia AG N Nguyen, L A George, J I Siner, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 30, 2017
A Novel Platform for Immune Tolerance Induction in Hemophilia A MiceSimone Merlin, Elvira Stefania Cannizzo, Ester Borroni, et al.
Thrombosis and Haemostasis|June 30, 2006
Early in vivo anticoagulation inhibits the angiogenic response following hindlimb ischemia in a rodent modelErich V De Paula, Mariane C F Nascimento, Celso D Ramos, et al.
Blood|May 16, 2014
Omental implantation of BOECs in hemophilia dogs results in circulating FVIII antigen and a complex immune responseMargareth C Ozelo, Barbara Vidal, Christine Brown, et al.
Human Gene Therapy|August 7, 2002
Influence of vector dose on factor IX-specific T and B cell responses in muscle-directed gene therapyRoland W Herzog, Paul A Fields, Valder R Arruda, et al.
American Journal of Hematology|January 1, 1994
Beta S-gene-cluster haplotypes in sickle cell anemia patients from two regions of BrazilF F Costa, V R Arruda, M G Gonçalves, et al.
Journal of Thrombosis and Haemostasis : JTH|February 26, 2021
Factor IX assay discrepancies in the setting of liver gene therapy using a hyperfunctional variant factor IX-PaduaMary M Robinson, Lindsey A George, Marcus E Carr, et al.
Pageof 19